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Abstract 
Aim: Visualization of Staphylococcus aureus biofilm using histochemical staining and combined 
histochemistry (HC) and immunohistochemistry (IHC). 
Methods: The ability of S. aureus S54F9 to form biofilm was tested in vitro. Hereafter, infected bone 
tissue was collected from two different porcine models of osteomyelitis inoculated with S. aureus 
strain S54F9. The infection time was five and fifteen days, respectively. Twenty-five different 
histochemical staining protocols were tested in order to find the stains that could identify 
extracellular biofilm matrix. Protocols with an optimal visualization of biofilm extracellular matrix 
were combined with an immunohistochemical protocol based on a specific antibody against S. 
aureus. The combined protocols were applied to the tissue from the porcine models and to infected 
bone tissue from a child suffering from chronic staphylococcal osteomyelitis for more than a year.  
Results: S. aureus S54F9 showed an ability to form biofilm in vitro. Visualization of biofilm, i.e. 
bacterial cells and extracellular matrix in different colours, was seen when the immunohistochemical 
protocol was combined with Alcian Blue pH3, Luna and Methyl-pyronin green. The bacterial cells 
were red to light brown and the extracellular matrix either light blue, blue or orange depending on 
the histochemical stain. In the porcine models and the human case 10 and 90 percent, respectively, 
of the bacterial aggregates in a 100x magnification field displayed both the extracellular matrix and 
the bacterial cells simultaneously in two different colours.  
Conclusions: A combination of HC and IHC can be used to diagnose and characterise biofilm 
infections on a routine basis. 
Key words: Biofilm, Staphylococcus aureus, bone infection, histology, light microscopy 
Introduction 
Bacterial biofilms are microbial derived 
communities, characterized by aggregates of bacterial 
cells that are attached to a substratum/interface or to 
each other and embedded in a matrix of extracellular 
polymeric substances [1-3]. Furthermore, the bacteria 
exhibit an altered phenotype in regard to growth, 
gene expression and protein production [2,3] and 
show increased tolerance towards antibiotics and the 
host immune system [3]. In most in-vitro biofilms, the 
bacteria account for less than 10 % of the dry mass, 
whereas the extracellular matrix can account for more 
than 90 % [4]. The extracellular matrix of a biofilm is 
composed of molecules produced both by the bacteria 
and the host and includes polysaccharides, structural 
proteins, enzymes, nucleic acids and lipids [4]. All the 
different molecules have specific roles in favour of the 
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survival and growth of the embedded bacteria (Table 
1) [4]. Despite extensive research focusing on bacterial 
biofilms, a comprehensive analysis of which histoche-
mical stains that can identify the components of the 
extracellular biofilm matrix is lacking. Therefore, 
pathologists are often not aware of the presence of 
biofilm formation when examining slides for 
diagnosing bacterial infection in routine diagnostic 
laboratories.  
 
Table 1. Function of major components of extracellular matrix 
(ECM) in bacterial biofilms, modified from [4]. 
Component Function 
Polysaccharides 
and proteins  
-Adhesion between biofilm components and surfaces 
-Aggregation and immobilization of bacterial cells 
-Polysaccharide-enzyme binding causing accumulation, 
retention and stabilization of enzymes 
-Cohesion of biofilms ensuring mechanical stability, 
architecture and cell communication 
-Enzymatic activity (just proteins) 
-Electron donor or acceptor, permitting redox activity 
within the biofilm matrix (just proteins) 
-Nutrient source for utilization by biofilm cells 
-Protective barrier conferring host defenses against infection 
and tolerance to antimicrobials 
-Retention of water providing a hydrated 
microenvironment  
-Promoting nutrient accumulation and detoxification of 
xenobiotics 
-Promoting ion exchange, mineral formation, detoxification 
of toxic metal ions and polysaccharide gel formation 
 
Nucleic acids -Adhesion between biofilm components and surfaces 
-Aggregation and immobilization of bacterial cells 
-Cohesion of biofilms ensuring mechanical stability, 
architecture and cell communication 
-Exchange of genetic information between biofilm cells 
-Nutrient source for utilization by biofilm cells 
Lipids -Adhesion between biofilm components and surfaces 
(amphiphilic molecules) 
-Nutrient source for utilization by biofilm cells 
 
Biofilm formation facilitates bacterial tolerance 
to elimination by antimicrobial agents, host phago-
cytic clearance and host oxygen radicals and proteases 
[5]. Therefore, biofilms are difficult to eradicate and 
present in many chronic diseases like cystic fibrosis, 
chronic wounds and orthopaedic infections [3]. In 
orthopaedics, biofilm has been identified inside 
necrotic bone tissue and on the surface of orthopaedic 
implants [4]. Staphylococcus aureus is one of the most 
common infectious agents in orthopaedics [5]. 
Recently, the porcine S. aureus strain S54F9 spa type 
t1333, originating from a porcine lung abscess [6], was 
characterized by whole-genome sequencing [7]. The 
strain has been used in various reproducible and 
discriminative porcine models of haematogenous 
osteomyelitis [8], implant-associated osteomyelitis [9], 
endocarditis [10] and sepsis [11]. Due to the infectious 
potential of S. aureus S54F9, its in-vitro production of 
biofilm was tested in the present study. Furthermore, 
histochemical stains, alone or combined with 
immunohistochemistry (IHC), were applied to tissue 
from experimental S. aureus S54F9 bone infections in 
pigs [8,9] and from a clinical S. aureus bone infection 
[12] in order to demonstrate S. aureus biofilm using 
light microscopy.  
Materials and methods 
In vitro biofilm formation  
The ability of S. aureus S54F9 to form biofilm was 
tested in a microtiter biofilm assay system as 
described by O’toole [13]. Both S. aureus S54F9 and S. 
aureus RN4220 (a reference strain) [14] were diluted to 
a final cell density of OD 0.005 in TSB (Sigma, USA) 
with 1% glucose. Of this solution, 150 µl was applied 
to each well of a 96-well microtiter plate (Thermo 
Fisher, USA). Plates were incubated for 24 hours at 
37˚C. After incubation the content was gently remov-
ed by inverting the plate. The wells were gently rinsed 
by adding 200 µl saline (0.9%) to each well. In order to 
fixate biomass, 180 µl methanol (Sigma, USA) was 
added to each well for 15 min. For staining, 180 µl 
Crystal Violet solution (CV) (Sigma, USA) was 
applied to the wells for 15 min. Two wells were left 
unstained for microscopy. The CV solution was 
removed by inverting the plate. Residue CV was 
removed by gently rinsing each well with 200 µl saline 
(0.9%). The plate was air-dried at room temperature. 
Bound CV was expelled by incubating the plate in 180 
µl 96.5% (V/V) EtOH for 15 min. The intensity of the 
CV staining was evaluated by OD measuring at 594 
nm on a VictorX4 plate reader (Perkin Elmer, USA). A 
t-test was used to show differences in OD 
measurements between the two S. aureus strains. For 
confocal microscopy, biofilm in the two CV unstained 
microtiter wells was stained with 0.3mM Syto9 
(Molecular Probes, USA) and incubated for 15 min. 
Microscopy was performed using an inverted Zeiss 
LSM 880 confocal microscope running the program 
Zen 2.1 (Ziess, Germany). Images were obtained with 
a 488 nm laser with an emission peak at 498-501 nm 
by using a 10x/0.3 and a 63x/1.4 objective. 3D 
projections of these images were produced using the 
program Imaris (Bitplane, Switzerland).  
Sampling of porcine bone tissue 
Two blocks of formalin-fixed, decalcified and 
paraffin embedded porcine infected bone tissue were 
used [9]. The first block contained tissue from a 
female pig inoculated with 104 CFU of S. aureus S54F9 
locally in the right tibia followed by insertion of a 
small steel implant (2x15 mm). The pig was 
euthanized following five days of inoculation [9]. The 
tissue block included the implant cavity and the 
surrounding infected metaphyseal (trabecular) bone 
tissue (Figures 1A + 1B). The second block originated 
from a female pig inoculated with 104 CFU/kg BW of 
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S. aureus S54F9 into the right femoral artery [8]. This 
pig was euthanized following 15 days of inoculation 
[8]. The tissue block was sampled from a bone lesion 
in the distal metaphysis of the right femur (Figures 1C 
+ 1D).  
Sampling of human bone tissue 
One block of formalin fixed, decalcified and 
paraffin embedded infected bone tissue from a 5 
year-old boy with chronic, haematogenous osteomye-
litis in the right femur, lasting for more than one year, 
was used [12]. The block had been sampled during 
therapeutic surgery and contained a large cortical 
sequester (Figures 1E + 1F). Microbiological testing 
demonstrated S. aureus as the infecting organism [12].  
Histochemistry (HC) 
Tissue sections of 4-5 µm from each of the two 
cases of porcine osteomyelitis and from the human 
case of osteomyelitis were stained with haematoxylin 
and eosin (HE). The HE stained sections of the lesions 
were used to describe the pathomorphology with 
regards to bone destruction, inflammatory cells and 
localization of bacteria. Furthermore, 25 consecutive 
sections of 4-5 µm were cut from both blocks of porci-
ne tissue and stained with the HC stains listed in 
Table 2. For all stains, the colour of bacterial clusters 
and the ability to visualize an extracellular biofilm 
matrix were recorded. Furthermore, the level of cont-
rast between the colour of the bacterial clusters and 
surrounding tissue (background) was scored: poor 
contrast (+), fair contrast (++), good contrast (+++).  
 
 
Figure 1. Bone tissue used in the present study. A: Porcine model of implant-associated osteomyelitis. CT scan after five days of inoculation demonstrating the tibial 
implant cavity (ic) used for injection of S. aureus and insertion of a small steel implant. B: Histology of picture A demonstrating bacteria (arrow) in the peri-implant 
tissue adjacent to the implant cavity (ic). HE. C: Porcine model of haematogenous osteomyelitis euthanized fifteen days after inoculation. A lesion is shown in the right 
femoral metaphysis. D: Histology of picture C demonstrating bacteria (arrow) centrally in the lesion. HE. E: X-ray of a child with haematogenous osteomyelitis and 
pathological fracture in the right femur. F: Histology of picture E demonstrating bacteria (arrow) in a cortical sequester. HE. 
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Table 2. Results of 25 histochemical stains, modified from the cited references, applied to bone tissue from porcine models of 
haematogenous and implant associated osteomyelitis induced with Staphylococcus aureus S45F9.  
Stain Staining pattern Bacteria color Matrix Contrast Protocol Reference 
Connective tissue stains 
Alkaline congo red Red: Amyloid (via. H-bonds), elastic fibers, eosinophil granules 
Blue: Nuclei 
Purple 
 
No 
 
++ 15 
Crystal violet Red-purple: Amyloid, mucin, renal hyaline 
Blue: Background 
Purple 
 
Yes 
Purple 
++ 15 
Gomori’s reticular fibers Black: Reticular fibers 
Gray: Nuclei 
Brown/purple 
 
No 
 
+ 15 
Luna Red: Eosinophils, RBC (red blood cells) 
Blue: Background 
Blue Yes 
Blue 
+++ 16 
Martius scarlet blue Blue: Nuclei, collagen, (old fibrin) 
Yellow: RBC, (early fibrin) 
Red: Muscle, fibrin 
Purple No 
 
+ 15 
Masson-trichome Blue/black: Nuclei 
Red: Cytoplasm, muscle, RBC 
Blue: Collagen 
Brown/purple No 
 
++ 15 
Picro-sirius red Red: Collagen type 1-3, keratohyalin granules 
Polarized light: Collagen 1 – yellow/orange/red, collagen 3 - 
green 
Orange Yes 
Orange 
++ 17  
PTAH Dark blue: Muscle striations, neuroglia, fibrin, amoebae 
Blue: Nuclei, cilia, RBC 
Light blue: Myelin 
Deep red-brown: Collagen, osteoid, cartilage, elastic fibers 
Pale pink-brown: Cytoplasm  
Brown/purple No 
 
 
+ 16 
 
Van Gieson Blue/black: Nuclei 
Red: Collagen 
Brown 
 
No 
 
+ 15 
Verhöeff’s Black: Elastic tissue fibers Purple No + 15 
Carbohydrate stains 
Alcian blue ph1 Blue: Acid mucins, proteoglycans, hyaluronic acid 
Red: Nuclei 
Blue 
 
Yes 
Blue 
 
+ 15 
Alcian blue ph3 Blue: Acid mucins, proteoglycans, hyaluronic acid 
Red: Nuclei 
Blue Yes 
Blue 
+++ 15 
PAS Magenta: Glycogen, neutral/sialomucins, glycoproteins 
Blue: Nuclei 
Purple 
 
Yes 
Purple 
 
++ 15 
Safranin O Black: Nuclei 
Grey/green: Cytoplasm 
Orange/red: Cartilage, mast cells 
Purple Yes  
Purple 
 
+++ 18 
Toluidine blue-acetone Blue/purple: Mast cell granula 
Blue: Nuclei and background 
Blue Yes 
Blue 
++ 15 
Lipid stains 
Oil-red O  Red: Fat 
Blue: Nuclei 
Purple Yes 
Purple 
++ 15 
Pigment and mineral stains 
Perls’ Prussian blue Blue: Ferric iron 
Red: Nuclei 
Red No 
 
++ 15 
Von kossa Black: Mineralized bone 
Red: Osteoid 
Brown No 
 
+ 15 
Alizarin red S Orange-red: Calcium deposits (especially small deposits) Yellow/brown 
 
No +/++ 15 
Microorganism stains 
Giemsa Dark blue: Protozoa, microorganisms 
Pink-pale blue: Background 
Blue: Nuclei 
Blue 
 
Yes 
Blue 
 
+++ 15 
 
Grocott methenamine-silver Black: Fungi, pneumocystis, melanin, hyphae, yeast form cells of 
fungi 
Taupe-dark gray: Mucins, glycogen 
Pale green: Background  
Black 
 
No 
 
++ 15 
Levaditis Black: Spirochaetes, some organisms and fungi 
Yellow: Background 
Black No 
 
++ 16 
Gram Blue/black: Gram positive bacteria 
Red: Gram negative bacteria 
Purple/blue Yes 
Purple/blue 
+++ 15 
Nucleic acid stains 
Feulgen nuclear reaction for 
DNA 
Red/purple: DNA 
Green: Cytoplasm 
Turquoise  No 
 
+ 15 
Methyl green-pyronin Green/blue: DNA 
Red: RNA 
Red/pink Yes 
Red/pink 
+++ 15 
Contrast: poor contrast (+), fair contrast (++), good contrast (+++) between bacteria and background. 
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Immunohistochemistry (IHC) towards S. 
aureus  
Porcine and human tissue sections of 4-5 µm 
were prepared and processed for indirect in situ 
identification of S. aureus. Primary S. aureus specific 
antibodies (ab37644, Abcam, Cambridge, UK, diluted 
1:2000 in 5% swine serum) targeting at antigen protein 
A were used. The specific protocol has recently been 
described (see also next section) [19]. The three 
smallest and three largest (diameter) IHC positive 
bacterial aggregates were measured using the 
software Delta Pix Insight (Smørum, Denmark).  
Combined IHC and HC 
HC stains demonstrating extracellular biofilm 
matrix and good contrast to the surrounding tissue 
(Table 2) were selected to be combined with IHC 
towards S. aureus. Consecutive tissue sections of 4-5 
µm from the porcine and human tissue blocks were 
mounted on adhesive glass slides (Thermo Scientific, 
Menzel GmbH & CoKG, Baunschweig, Germany). 
Following deparaffinization, antigen retrieval 
procedures were carried out by treatment with a 
Trypsin solution (Sigma-Aldrich, St. Louis, Missouri, 
USA) pH 7.8 for 30 min at 37 ºC. This was followed by 
blocking of endogenous peroxidase by 0.6% H2O2 for 
15 min and blocking of unspecific protein binding by 
Ultra V Block (AH-diagnostics, Aarhus, Denmark) for 
five min. Tissue sections were incubated with the 
primary antibodies overnight followed by the applic-
ation of a primary antibody enhancer, horseradish 
peroxidase polymer and aminoethylcabazol/3,3’- 
diaminobenzidine as described by the manufacturer 
(AH-diagnostics, Aarhus, Denmark). Throughout the 
immune-staining protocol, tissue sections were 
washed in Tris-buffered saline pH 7.6. After the IHC 
steps, the HC protocols with good contrast (Table 2) 
were applied, and all tissue sections were mounted 
with glycerol–gelatin and a cover slip. For each of the 
porcine and human tissue sections stained with the 
combined IHC and HC protocols, the number of 
bacterial aggregates with and without a visible 
biofilm matrix were registered in a 100x magnification 
field.  
Image analysis 
Combined IHC and HC stained porcine and 
human tissue sections were scanned using Zeiss Axio 
Scan.Z1 at a 10x objective and imported into 
Visiopharm Integrator System 4.6.857. The 
Visiopharm software was trained to recognize and 
stain positive areas of S. aureus (yellow) and 
extracellular matrix (purple). Pre-processing median 
filters for red/green/blue bands and the bayessian 
classification method were applied to improve image 
quality and recognition ability. On each tissue section, 
a representative bacterial aggregate demonstrating 
both bacterial cells and extracellular matrix was 
outlined. The Visiopharm software was used to 
identify and calculate the percentage of S. aureus and 
extracellular matrix positive areas within the outlined 
bacterial aggregate.  
Results  
In vitro biofilm formation  
S. aureus S54F9 produced the same amount (P = 
0.4693) of attached biomass as the known biofilm 
producing strain RN4220 (Figure 2A). A dense layer 
of biomass was visible in the bottom of the microtiter 
trays wells. At a higher magnification (630x), a 
compact layer of coccid bacteria comparable to S. 
aureus was seen (Figure 2B) [13,20].  
 
 
Figure 2. Biofilm formation in vitro. A: Attached biomass of reference strain RN4220 and S54F9 in the wells of microtiter trays based on the binding of crystal violet. 
Mean OD594 with SEM. B: 3D projection of the bottom of a microtiter well stained for bacterial cells with green Syto9. 630 x magnification.  
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Histochemistry 
The porcine (5 day) tibial lesion consisted of 
necrotic trabecular bone debris, intermingled with 
accumulations of neutrophilic granulocytes and 
bacterial aggregates (Figure 1B). The porcine (15 day) 
femoral lesion consisted centrally of sequestered 
trabecular bone tissue with empty lacuna. The dead 
bone tissue was surrounded by neutrophilic 
granulocytes and aggregates of bacteria (Figure 1D). 
Macrophages and fibroblasts encapsulated the area 
(Figure 1D). The human tissue consisted of necrotic 
cortical bone tissue. The lamellar cortical bone 
structure could be observed in the sequestrum, and 
aggregates of bacteria and few inflammatory cells 
were located within Volkmann canals and the 
Haverisian system (Figure 1F). In the porcine tissues, 
six HC stains (Table 2) revealed the presence of an 
extracellular biofilm matrix and good contrast to the 
surrounding tissue (Figures 3B-F, Table 2).  
 
 
Figure 3. Immunohistochemical (A), histochemical (B-L) and combined histochemical/immunohistochemical (M-O) stains applied to porcine S. aureus infected bone 
tissue. A: S. aureus immunohistochemistry, B: Alcian blue pH3, C: Luna, D: Methyl green-pyronin, E: Safranin O, F: Gram, G: Crystal Violet, H: Oil red, I: Feulgen, J: 
Verhoeff, K: Alzian Red, L: Masson trichome, M: Alcian blue pH 3 + S. aureus immunohistochemistry, N: Luna + S. aureus immunohistochemistry, O: Methyl 
green-pyronin + S. aureus immunohistochemistry. All pictures are at 60x magnification  
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Figure 4. Composition and size of biofilm forming infections in porcine and human bone tissue. A: Size of the three smallest and three largest bacterial aggregates 
seen with immunohistochemistry towards S. aureus, Mean ± SD. B-D: Number of bacterial aggregates with and without a visible extracellular biofilm matrix at 100x 
magnification following combined histochemistry with immunohistochemistry. The x-axis shows the histochemical stains. E: Percentage of bacterial cells and 
extracellular matrix in single representative S. aureus biofilm aggregates. AB: Alcian Blue pH3, MGP: Methyl-pyronin green, DPI: days post infection, ECM: extracellular 
matrix. 
 
Immunohistochemistry towards S. aureus  
IHC staining towards S. aureus successfully 
demonstrated the presence of S. aureus in both porcine 
and human bone tissue (Figure 3A). Positive S. aureus 
bacteria were stained red. The size of the three 
smallest and three largest bacterial aggregates are 
shown in Figure 4A. 
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Combined immunohistochemistry and 
histochemistry 
Of the six HC stains with good contrast and 
visible biofilm matrix, Alcian blue pH 3, Luna and 
Methyl green-pyronin (Table 2) were found to be 
optimal for combination with IHC. The remaining 
three good HC stains, i.e. Safranin O, Giemsa and 
Gram (Table 2) resulted in purple or blue bacterial 
aggregates which combined with IHC resulted in a 
brown indefinite mass. Alcian blue pH3, Luna or 
Methyl green-pyronin combined with IHC stained the 
bacterial cells red to light brown and the extracellular 
matrix light blue, blue or orange, respectively (Figures 
3M-O). Extracellular matrix and bacteria were 
simultaneously seen in 3-10 % and 80-100 % of the 
bacterial aggregates in the porcine and human bone 
tissue, respectively (Figures 4B-D). For the single 
representative bacterial aggregates used to determine 
the bacterial cell/extracellular matrix ratio, a higher 
ratio of extracellular matrix than bacterial cells was 
seen in the human tissue compared to the two porcine 
models (Figure 4E and Figure 5).  
 
 
Figure 5. Percentage of bacteria and extracellular matrix in S. aureus biofilm infections. Left column: combined immunohistochemistry (towards S. aureus) and Alcian 
blue pH3 staining of representative bacterial biofilms (red outline) displaying both bacteria (red/brown) and extracellular matrix(blue). Right column demonstrates 
calculations of % bacterial cells (yellow) and extracellular matrix (purple). A+B: Bone tissue from a porcine model of S. aureus implant-associated osteomyelitis 
infected for five days. Bar = 40 µm. C+D: Bone tissue from a porcine model of S. aureus haematogenous osteomyelitis infected for fifteen days. Bar = 78 µm. E+F: Bone 
tissue from a patient suffering from S. aureus haematogenous osteomyelitis for more than one year. Bar = 72 µm. 
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Discussion  
Biofilm is typically found in chronic infections, 
which means that the infection persists despite 
adequate antibiotic therapy and host immune defence 
mechanisms [21]. Therefore, increased focus has been 
on diagnosing and treating bacterial biofilm infections 
[21]. In the present study, S. aureus S54F9 showed the 
ability to form biofilm in vitro. The histochemically 
stained bacterial aggregates seen in the porcine 
osteomyelitis models (inoculated with S54F9), 
therefore, likely represent in vivo biofilm produced by 
S. aureus S54F9. Likewise, the HC and IHC double 
coloured bacterial clusters seen in the human tissue 
also represent biofilm produced by S. aureus.  
Recently, ESCMID (European Society for Clinical 
Microbiology and Infectious Diseases) published 
guidelines for diagnosing biofilm infections [21]. 
According to these guidelines, biofilm detection 
requires that tissue microscopy shows evidence of an 
infective process, such as the presence of leucocytes, 
and that the microorganisms present form aggregates 
embedded in a self-produced matrix distinct from the 
surrounding tissue [21]. These requirements were 
achieved with the present combination of HC and 
IHC staining’s for light microscopy. Light microscopy 
is one of the most common methods by which bacteria 
are demonstrated in tissue [22]. Bacteria can be 
visualized in routine HE stains, although a 
disadvantage of HE staining is that haematoxylin 
stains all nucleic acids, which may make it difficult to 
distinguish microbial cells from host cells [22]. To 
specifically detect bacteria with HC stains, the Gram 
stain can be used [15]. HC stains are commonly used 
to demonstrate different molecules in tissue sections 
based on chemical properties. Therefore, it is 
reasonable to suggest that the biofilm extracellular 
matrix can be visualized by different HC stains due to 
its content of carbohydrates, proteins, lipids and 
nucleic acids (Table 2). A limited number of studies 
demonstrating bacterial biofilm by HC and light 
microscopy exists [23-25]. In these studies, PAS, 
Giemsa, Gram or HE stains have been applied to 
demonstrate bacterial biofilms [23-25]. Also more 
advanced microscopic techniques have been used to 
visualize biofilm, e.g. confocal laser scanning 
microscopy, fluorescence microscopy, scanning 
electron microscopy, and transmissions electron 
microscopy [26]. A combination of confocal 
microscopy and reverse transcriptase-polymerase 
chain reaction has been described as a powerful tool 
for detection of biofilms in operative tissue specimens 
[27]. Confocal laser scanning microscopy and electron 
microscopy are, however, specialized and time 
consuming techniques based on equipment not 
generally available in diagnostic laboratories [28].  
Although the present combinations of HC and 
IHC protocols were able to demonstrate biofilm 
formation by S. aureus, a negative result can not 
exclude the presence of biofilm. Furthermore, one 
should be aware of the fact that extracellular biofilm 
matrix components differ amongst different bacteria 
and bacterial strains. In a clinical situation, a 
combined staining technique can not be applied 
before the results of microbiology are available in 
order to select adequate antibodies for IHC. 
Therefore, the introduction of combined HC and IHC 
staining, as demonstrated in this study, is not useful 
in facilitating fast histopathological diagnosis of 
infections. However, it is useful for facilitating the 
demonstration of bacterial biofilm formation, which 
may impact the selected treatment protocol. 
Histologically, diagnosis of bone infection should not 
rely only on bacterial identification, but also on the 
patho-morphology present. 
Biofilm extracellular matrix components include 
polysaccharides, lipids, proteins and extracellular 
DNA (Table 1). The light blue colour of the biofilm 
matrix seen with the Alcian Blue pH3 stain is due to a 
chemical reaction with polysaccharides. The blue and 
orange colours of biofilm matrix seen with Luna and 
Methyl-green pyronin, respectively, are due to 
haematoxylin and methyl-green which both stain 
nucleic acids. Extracellular DNA has been identified 
as a major structural component in the biofilm matrix 
of S. aureus, whereas it is only a minor component of 
biofilm formed by S. epidermidis [29]. In a review 
concerning biofilm formation in vivo, it was recently 
shown that tissue biofilm aggregates in chronic 
infections of humans, including orthopaedic 
infections, despite anatomical location and type of 
bacteria involved have an upper size limit of 
approximately 200 µm [30]. None of the measured 
bacterial aggregates in the present study exceeded 
this limit. According to Bjarnsholt et al. [30] and 
Parsek et al. [31] the human osteomyelitis case of the 
present study fulfils all criteria for a biofilm infection. 
This includes tissue adherent pathogenic bacteria 
found in clusters with a diameter within the range of 
~5-200 µm [30], infection localized to a particular 
anatomic site and persistent infection despite 
exposure to antibiotics [30].  
Conclusion 
• The porcine S. aureus strain S54F9 has the ability 
to form biofilm both in vitro and in vivo and is, 
therefore, a reliable agent to be used in animal 
models of human chronic infectious diseases 
caused by S. aureus. 
• A combination of HC and IHC can be used to 
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diagnose and characterise biofilm infections. 
Furthermore, a list of how biofilm is stained by 
histochemical stains available in most routine 
diagnostic laboratories is provided.  
Abbreviations 
IHC: immunohistochemistry; HC: histochem-
istry, CFU: colony-forming unit, OD: optical density; 
CV: Crystal Violet solution; HE: haematoxylin and 
eosin. 
Acknowledgements 
We would like to thank Betina Andersen and 
Elizabeth Petersen for excellent laboratory assistance 
and the Core Facility for Integrated Microscopy at The 
University of Copenhagen for assistance with 
scanning of tissue sections.  
Funding 
This study was financed by grant no. 
4005-00035B from the Danish Research Council and 
the European Union’s Horizon 2020 research and 
innovation program under NOMORFILM project 
grant agreement No 634588 and grant no. 
R173-2014-584 and R105-A9791 from the Lundbeck 
Foundation to TB. 
Ethical Approval 
The porcine tissue blocks were collected from 
studies [8,9] approved by the Danish Animal 
Experimental Act (Licence no. 2013/15-2934-00946 
and 2008/561-37). The human tissue block was 
collected from a study [12] approved by the Danish 
National Committee on Biomedical Research Ethics 
(Protocol no. H-2-2011-102). 
Competing Interests 
The authors have declared that no competing 
interest exists. 
References 
1 Costerton JW, Geesey GG, Cheng K-J. How bacteria stick. Sci Am. 1978; 238: 
86-95. 
2 Donlan RM, Costerton WJ. Biofilms: survival mechanisms of clinically 
relevant microorganisms. Clin Microbiol Rev. 2002; 15: 167-193. 
3 Bjarnsholt T. The role of bacterial biofilms in chronic infections. APMIS. 2013; 
121: 1-51. 
4 Flemming H-C, Wingender J. The biofilm matrix. Nature Rev Microbiol. 2010; 
8: 623-633.  
5 Brady RA, Leid JG, Calhoun JH, et al. Osteomyelitis and the role of biofilms in 
chronic infection. FEMS Immunol Med Microbiol. 2008; 52: 13-22. 
6 Hasman H, Moodley A, Guardabassi L, et al. spa type distribution in 
Staphylococcus aureus originating from pigs, cattle and poultry. Vet Microbiol. 
2010; 141: 326-331. 
7 Aalbæk B, Jensen LK, Jensen HE, et al. Whole-genome sequence of 
Staphylococcus aureus S54F9 isolated from a chronic disseminated porcine lung 
abscess and used in human infection models. Genome Announc. 2015; 3: 1-2. 
8 Johansen LK, Koch J, Frees D, et al. Pathology and biofilm formation in a 
porcine model of staphylococcal osteomyelitis. J Comp Path. 2012; 147: 
343-353. 
9  Jensen LK, Koch J, Dich-Jorgensen K, et al. Novel porcine model of 
implant-associated osteomyelitis: A comprehensive analysis of local, regional 
and systemic response. J Orthop Res. 2017; doi: 10.1002/jor.23505: 1-11. 
10 Christiansen JG, Jensen HE, Johansen LK, et al. Porcine models of 
non-bacterial thrombotic endocarditis (NBTE) and infective endocarditis (IE) 
caused by Staphylococcus aureus: A preliminary study. J Heart Valve Dis. 2013; 
22: 368-376. 
11 Sørensen KE, Skovgaard K, Heegaard PMH et al. The impact of Staphylococcus 
aureus concentration on the development of pulmonary lesions and cytokine 
expression after intravenous inoculation of pigs. Vet Pathol. 2012; 49: 950-962. 
 12  Johansen LK, Koch J, Kirketerp-Møller K, et al. Therapy of haematogenous 
osteomyelitis – a comparative study in a porcine model and Angolan children. 
In vivo. 2013; 27: 305-312. 
13 O’Toole GA. Microtiter dish biofilm formation assay. J Vis Exp. 2011; 
doi:10.3791/2437: 1-2. 
14 Malone CL, Boles BR, Lauderdale KJ, et al. Flourescent reporters for 
Staphylococcus aureus. J Microbiol Methods. 2009; 77: 251-260. 
15 Bancroft, J.D. & Gamble, M. Theory and practice of histological techniques. 
New York, USA: Churchill Livingstone Elsevier; 2008. 
16 Luna LG. Manual of histologic and methods of the armed forces institute of 
pathology. New York, USA: McGraw-Hill; 1960. 
17 Pearse SGE. Histochemistry theoretical and applied. New York, USA: 
Churchhill Livingstone; 1985. 
18 Lille RD, Fullmer HM. Histopathologic technic and practical histochemistry. 
New York, USA: McGraw-Hill; 1965. 
19 Johansen LK, Frees D, Aalbæk B, et al. A porcine model of acute, 
haematogenous localized osteomyelitis due to Staphylococcus aureus: a 
pathomorphological study. APMIS. 2011; 119: 111-118. 
20 Yarwood JM, Bartels DJ, Volper EM, et al. Quorum sensing in Staphylococcus 
aureus biofilms. J Bacteriol. 2004; 186: 1838–1850. 
21 Høiby N, Bjarnsholt T, Moser C, et al. ESCMID guideline for the diagnosis and 
treatment of biofilm infections 2014. Clin Microbiol Infect. 2015; 21: S1-S25. 
22 Rumbaugh KP, Carty NL. In vivo models of biofilm infection. In: Bjarnsholt T, 
ed. Biofilm infections, 1st ed. New York: Springer-Verlag; 2011: 267-290. 
23 Winther B, Gross BC, Hendley JO, et al. Location of bacterial biofilm in the 
mucus overlaying the adenoid by light microscopy. Arch Otolaryngol Head 
Neck Surg. 2009; 135: 1239-1245. 
24 Hochstim CJ, Choi JY, Lowe D, et al. Biofilm detection with hematoxylin-eosin 
staining. Arch Otolaryngol Head Neck Surg. 2010; 136: 453-456. 
25 Tóth L, Csomor P, Sziklai I, et al. Biofilm detection in chronic rhinosinusitis by 
combined application of hematoxylin-eosin and gram staining. Eur Arch 
Otorhinolaryngol. 2011; 268: 1455-1462. 
26 Harrison-Balestra C, Cazzangia AL, Davis SC, et al. A wound-isolated 
Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is 
visualized by light microscopy. Dermatol Surg. 2003; 29: 631-635.  
27 Stoodley P, Nistico L, Johnson S et al. Direct demonstration of viable 
Staphylococcus aureus biofilms in an infected total joint arthroplasty. J Bone 
Joint Surg Am. 2008; 90: 1751-1758. 
28 Izano EA, Amarante MA, Kher WB, et al. Differential roles of 
poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in 
Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ 
Microbiol. 2008; 74: 470-476. 
29 Ziran BH. Osteomyelitis. J Trauma. 2007; 62: 59-60.  
30 Bjarnsholt T, Alhede M, Alhede M, et al. The in vivo biofilm. Trends Microbiol. 
2013; 21: 466-474. 
31 Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease 
pathogenesis. Annu Rev Microbiol. 2003; 57: 677-701. 
 
